-The Telegraph Dispur has decided to provide free treatment to children below 12 years who are suffering from blood cancer or leukaemia. Health minister Himanta Biswa Sarma today said Dispur was working on the project and hoped to launch it on Independence Day. He told this correspondent that considering the huge cost of treatment for leukaemia, the government was also considering free treatment for adults below poverty line and subsidised rates for those...

-The Economic Times It is not malaria or TB that will be the cause of large number of deaths in the world, Cancer is on its way to become one the deadliest diseases in the coming decades, according to a research paper published in medical journal Lancet. The study lead by Dr Freddy Bay of International Agency for Research on Cancer, France,predicts that the number of cancer patients in the world is...

Those who violate ban may be fined up to Rs 5 lakh or imprisoned up to six years After Madhya Pradesh, Kerala has now become the second state in India to ban all forms of chewing tobacco products. The state has banned the manufacture, storage, distribution and sale of gutkha and pan masala, containing tobacco and nicotine, of all brands available in the market. The ban is effective from May 25. Like Madhya...

-The United Nations The number of people with high blood pressure and diabetes is drastically increasing in both developed and developing countries, according to a United Nations report released today. “This report is further evidence of the dramatic increase in the conditions that trigger heart disease and other chronic illnesses, particularly in low- and middle-income countries,” said the Director-General of the World Health Organization (WHO), Margaret Chan. “In some African countries, as...

Health activists and cancer patients in the US have pounced on Swiss drug multinational Novartis for the high price of its famous, multi-billion dollar anti-cancer drug Glivec, a development which challenges pharma MNCs' claims of cheap access and affordability for patented drugs. Such protests, which began first in Europe, and have now spread to the US, could make it more difficult for pharma MNCs in developing countries to convince sceptical governments...